Drugmaker Eli Lilly reported Thursday a profit for the fourth quarter that decrease 18 percent from last year, reflecting a steep reduction in other income and lower operating income, partially offset by lower income tax expense. However, both adjusted earnings per share and revenues topped analysts' expectations. The company also reaffirmed its full-year 2022 earnings and revenue guidance.
from RTT - Top Story https://ift.tt/a3uWoKvxD
via IFTTT
from RTT - Top Story https://ift.tt/a3uWoKvxD
via IFTTT
Comments
Post a Comment